Korean J Intern Med.  2016 May;31(3):601-604. 10.3904/kjim.2014.292.

Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor α inhibitor therapy

Affiliations
  • 1Division of Nephrology, Department of Internal Medicine, Chosun University Medical School, Gwangju, Korea. hyunkim@chosun.ac.kr
  • 2Division of Rheumatology, Department of Internal Medicine, Chosun University Medical School, Gwangju, Korea.

Abstract

No abstract available.

Keyword

Cyclophosphamide; Amyloidosis; Juvenile idiopathic arthritis

MeSH Terms

Amyloidosis*
Arthritis, Juvenile*
Cyclophosphamide*
Humans
Tumor Necrosis Factor-alpha*
Cyclophosphamide
Tumor Necrosis Factor-alpha
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr